Rapid Testing of Advanced Therapy Medicinal Products (ATMPs)

Rapid Testing of Advanced

Therapy Medicinal Products (ATMPs)

Rapid Testing of Advanced Therapy Medicinal Products (ATMPs)

Rapid Testing of Advanced Therapy Medicinal Products (ATMPs)

Maintaining sterility in ATMP manufacturing is vital, but traditional tests are too slow (up to 14 days) for these short shelf-life products.

Red One™ accelerates detection by staining microorganisms based on their metabolic activity.

To distinguish them from active mammalian cells, Redberry uses a reagent that selectively lyses cells while preserving microorganisms, allowing rapid and accurate differentiation based on automated Solid-Phase Cytometry (SPC).

Rapid Screening in 10 minutes

Rapid Screening in 10 minutes

Rapid Screening in 10 minutes

The selective lysis step can be directly performed on fresh culture of cells.

This technique’s efficacy was validated on various cell types, including HeLa, Jurkat, Stem, CAR-T, and CHO cells.

In this case, the DVC application provides a direct count (excluding spores) in 10 minutes on samples ranging from 500µL to 2mL.


Efficiency of lysis on mammalian cells

Detection reduction >99,99%

The selective lysis step can be directly performed on fresh culture of cells.

This technique’s efficacy was validated on various cell types, including HeLa, Jurkat, Stem, CAR-T, and CHO cells.

In this case, the DVC application provides a direct count (excluding spores) in 10 minutes on samples ranging from 500µL to 2mL.


Efficiency of lysis on mammalian cells

Detection reduction >99,99%

 Rapid Release Testing in 6 hours (as per Eur. Ph. 2.6.27)

Rapid Release Testing in 6 hour

(as per Eur. Ph. 2.6.27)

 Rapid Release Testing in 6 hours (as per Eur. Ph. 2.6.27)

It complies with the European Pharmacopoeia 2.6.27, considering a detection limit of 100 CFU.

The process requires an activation phase similar to the Bioburden application.

Anaerobic strains are detected after 6 hours.

Detection of 50 S. aureus (SA) spiked in cellular products 50 CFU of S. aureus spiked in cellular products after lysis treatment

It complies with the European Pharmacopoeia 2.6.27, considering a detection limit of 100 CFU.

The process requires an activation phase similar to the Bioburden application.

Anaerobic strains are detected after 6 hours.

Detection of 50 S. aureus (SA) spiked in cellular products 50 CFU of S. aureus spiked in cellular products after lysis treatment

 Sterility Testing in 4 days (as per EP 2.6.1)

Sterility Testing in 4 days

(as per EP 2.6.1)

 Sterility Testing in 4 days (as per EP 2.6.1)

The workflow strictly relies on Red One™ Sterility Sample & Analysis application based on the compendial sample preparation in FTM and TSB media.

After the selective lysis step, a small sample (1 to 10mL) is analyzed on Red One™, with results delivered in 96 hours (instead of 14 days).

Further identification remains possible with the content remaining in bottles.